Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Abaxis, Inc., Medical Equipment, Deals By Year, 2004 to YTD 2010 4
Abaxis, Inc., Medical Equipment Deals By Type, 2004 to YTD 2010 5
Abaxis, Inc., Medical Equipment, Deals By Region, 2004 to YTD 2010 6
Abaxis, Inc., Medical Equipment, Deals By Market, 2004 to YTD 2010 7
Abaxis, Inc., Medical Equipment, Deals Summary, 2004 to YTD 2010 8
Abaxis, Inc., Medical Equipment, Deal Details 9
Partnerships 9
Abaxis Enters Into Licensing Agreement With bioMerieux 9
Cepheid Enters Into Licensing Agreement With Abaxis 10
Abaxis Signs Co-Marketing Agreement With Cardinal Health 11
Key Competitors 12
Key Employees 12
Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Recent Developments 14
Strategy And Business Planning 14
Apr 07, 2009: Abaxis Reorganizes North American Medical Sales And Marketing 14
Financial Announcements 14
Jan 28, 2010: Abaxis Reports Net Income Of $3.4 Million In Q3 Fiscal 2010 14
Oct 27, 2009: Abaxis Reports Net Income Of $3.2 Million In Q2 Fiscal 2010 15
Jul 30, 2009: Abaxis Posts Net Income Of $3.8 Million In Q1 Fiscal 2010 16
Apr 29, 2009: Abaxis Reports $12 Million Net Income For Fiscal 2009 16
Jan 29, 2009: Abaxis Reports Q3 Fiscal 2009 Results 17
Oct 27, 2008: Abaxis Reports 2Q Fiscal 2009 Results 18
Jul 24, 2008: Abaxis Declares 1Q Fiscal 2009 Results 19
May 01, 2008: Abaxis Declares Q4 Fiscal 2008 Results 20
Jan 31, 2008: Abaxis Declares Q3 Fiscal 2008 Results 21
Oct 24, 2007: Abaxis Declares Q2 Fiscal 2008 Results 22
Jul 26, 2007: Abaxis Reports Q1 2008 Results 23
Apr 26, 2007: Abaxis Reports Q4 2007 Results 24
Jan 25, 2007: Abaxis Reports Q3 2007 Results 24
Oct 25, 2006: Abaxis Reports Q2 2007 Results 25
Corporate Communications 25
Aug 10, 2009: Abaxis Appoints Brenton Hanlon As VP, North American Medical Sales And Marketing 25
Jun 18, 2007: Abaxis COO Resigns 26
Other Significant Developments 26
Nov 11, 2008: Abaxis To Present At The Stephens Inc. Fall Investment Conference In New York 26
Appendix 27
Methodology 27
About Global Markets Direct 27
Contact Us 27
Disclaimer 27
[Cerrar la tabla de contenidos]